Cargando…

P7C3 Inhibits LPS-Induced Microglial Activation to Protect Dopaminergic Neurons Against Inflammatory Factor-Induced Cell Death in vitro and in vivo

Parkinson’s disease (PD) is the second most common neurodegenerative disorder. Although its pathogenesis remains unclear, growing evidencce suggests that microglia-mediated neuroinflammation contributes greatly to the progression of PD. P7C3, an aminopropyl carbazole, possesses significant neuroprot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Chao, Hu, Qingsong, Wu, Jiayuan, Mu, Chenchen, Ren, Haigang, Liu, Chun-Feng, Wang, Guanghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230654/ https://www.ncbi.nlm.nih.gov/pubmed/30455635 http://dx.doi.org/10.3389/fncel.2018.00400

Ejemplares similares

P7C3 inhibits GSK3β activation to protect dopaminergic neurons against neurotoxin-induced cell death in vitro and in vivo
por: Gu, Chao, et al.
Publicado: (2017)

DJ-1 inhibits microglial activation and protects dopaminergic neurons in vitro and in vivo through interacting with microglial p65
por: Lin, Zixuan, et al.
Publicado: (2021)

Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson’s Disease Models
por: Huang, Bingxu, et al.
Publicado: (2017)

The induction of neuronal death by up-regulated microglial cathepsin H in LPS-induced neuroinflammation
por: Fan, Kai, et al.
Publicado: (2015)

Diosgenin Prevents Microglial Activation and Protects Dopaminergic Neurons from Lipopolysaccharide-Induced Neural Damage In Vitro and In Vivo
por: Lee, Shou-Lun, et al.
Publicado: (2021)

Deficient chaperone-mediated autophagy facilitates LPS-induced microglial activation via regulation of the p300/NF-κB/NLRP3 pathway
por: Wu, Jin, et al.
Publicado: (2023)

DAP12 and CD11b contribute to the microglial-induced death of dopaminergic neurons in vitro but not in vivo in the MPTP mouse model of Parkinson’s disease
por: Kinugawa, Kiyoka, et al.
Publicado: (2013)

Tiagabine Protects Dopaminergic Neurons against Neurotoxins by Inhibiting Microglial Activation
por: Liu, Jie, et al.
Publicado: (2015)

Auraptene and Other Prenyloxyphenylpropanoids Suppress Microglial Activation and Dopaminergic Neuronal Cell Death in a Lipopolysaccharide-Induced Model of Parkinson’s Disease
por: Okuyama, Satoshi, et al.
Publicado: (2016)

L166P mutant DJ-1 promotes cell death by dissociating Bax from mitochondrial Bcl-X(L)
por: Ren, Haigang, et al.
Publicado: (2012)

Ghrelin inhibits LPS-induced release of IL-6 from mouse dopaminergic neurones
por: Beynon, Amy L, et al.
Publicado: (2013)

JNK-mediated microglial DICER degradation potentiates inflammatory responses to induce dopaminergic neuron loss
por: Wang, Qing, et al.
Publicado: (2018)

NADPH-Oxidase, Rho-Kinase and Autophagy Mediate the (Pro)renin-Induced Pro-Inflammatory Microglial Response and Enhancement of Dopaminergic Neuron Death
por: Lopez-Lopez, Andrea, et al.
Publicado: (2021)

Ganoderma lucidum Protects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation
por: Zhang, Ruiping, et al.
Publicado: (2011)

Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase
por: Jiang, Lulu, et al.
Publicado: (2016)

Microglial activation induces neuronal death in Chandipura virus infection
por: Verma, Abhishek Kumar, et al.
Publicado: (2016)

Desipramine Protects Neuronal Cell Death and Induces Heme Oxygenase-1 Expression in Mes23.5 Dopaminergic Neurons
por: Lin, Hsiao-Yun, et al.
Publicado: (2012)

Interleukin-4 Protects Dopaminergic Neurons In vitro but Is Dispensable for MPTP-Induced Neurodegeneration In vivo
por: Hühner, Laura, et al.
Publicado: (2017)

ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo
por: Barcia, Carlos, et al.
Publicado: (2012)

Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models
por: He, Dewei, et al.
Publicado: (2023)

Natural Potent NAAA Inhibitor Atractylodin Counteracts LPS-Induced Microglial Activation
por: Yang, Longhe, et al.
Publicado: (2020)

Down-regulation of microglial activity attenuates axotomized nigral dopaminergic neuronal cell loss
por: Song, Dae-Yong, et al.
Publicado: (2013)

LPS-Activated Microglial Cell-Derived Conditioned Medium Protects HT22 Neuronal Cells against Glutamate-Induced Ferroptosis
por: Jacques, Mauricio Tavares, et al.
Publicado: (2023)

Autophagy down regulates pro-inflammatory mediators in BV2 microglial cells and rescues both LPS and alpha-synuclein induced neuronal cell death
por: Bussi, Claudio, et al.
Publicado: (2017)

Microglial activation induced by LPS mediates excitation of neurons in the hypothalamic paraventricular nucleus projecting to the rostral ventrolateral medulla
por: Han, Tae Hee, et al.
Publicado: (2021)

Cytokine Profiling in Human iPSC-Derived Dopaminergic Neuronal and Microglial Cultures
por: Knappe, Evelyn, et al.
Publicado: (2023)

Cascade Signals of Papaverine Inhibiting LPS-Induced Retinal Microglial Activation
por: Zhou, Ting, et al.
Publicado: (2019)

Hydroxytyrosol Decreases LPS- and α-Synuclein-Induced Microglial Activation In Vitro
por: Gallardo-Fernández, Marta, et al.
Publicado: (2019)

7,8-Dihydroxyflavone Protects Nigrostriatal Dopaminergic Neurons from Rotenone-Induced Neurotoxicity in Rodents
por: Nie, Shuke, et al.
Publicado: (2019)

Quercetin and Sesamin Protect Dopaminergic Cells from MPP(+)-Induced Neuroinflammation in a Microglial (N9)-Neuronal (PC12) Coculture System
por: Bournival, Julie, et al.
Publicado: (2012)

Quercetin Protects against MPP(+)/MPTP-Induced Dopaminergic Neuron Death in Parkinson's Disease by Inhibiting Ferroptosis
por: Lin, Zhi-Hao, et al.
Publicado: (2022)

Dopaminergic neurons show increased low-molecular-mass protein 7 activity induced by 6-hydroxydopamine in vitro and in vivo
por: Mo, Ming-Shu, et al.
Publicado: (2018)

Microglial MT1 activation inhibits LPS‐induced neuroinflammation via regulation of metabolic reprogramming
por: Gu, Chao, et al.
Publicado: (2021)

Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons
por: Hong, J, et al.
Publicado: (2015)

Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons
por: Goloborshcheva, Valeria V., et al.
Publicado: (2022)

Anti-Inflammatory Activity of Panduratin A against LPS-Induced Microglial Activation
por: Jamornwan, Sopana, et al.
Publicado: (2022)

Inhibition of LPS-Induced Microglial Activation by the Ethyl Acetate Extract of Pueraria mirifica
por: Jantaratnotai, Nattinee, et al.
Publicado: (2022)

Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo
por: Lee, Shou-Lun, et al.
Publicado: (2022)

Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease
por: Lim, L, et al.
Publicado: (2012)

Lobeline shows protective effects against MPTP-induced dopaminergic neuron death and attenuates behavior deficits in animals
por: LI, CHAO-YUE, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8tsbro9ulu5dldd95i6uqitmjf